nandrolone has been researched along with tamoxifen in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Bradbeer, JW; Pain, JA; Wickremesinghe, SS | 1 |
| Huovinen, R; Johansson, R; Kellokumpu-Lehtinen, P | 1 |
| Alanko, A; Gröhn, P; Heinonen, E; Rissanen, P | 1 |
| Alanko, A; Heinonen, E; Scheinin, T; Tolppanen, EM; Vihko, R | 1 |
| Collins, AT; Gilmore, K; Neal, DE; Zhiming, B | 1 |
| Botella, J; Delansorne, R; Duc, I; Duranti, E; Paris, J; Viader, V | 1 |
| Williams, SJ; Wood, RI | 1 |
| Fernández-Guasti, A; Phillips-Farfán, BV; Romano-Torres, M | 1 |
3 trial(s) available for nandrolone and tamoxifen
| Article | Year |
|---|---|
Combined tamoxifen and anabolic steroid as primary treatment for breast carcinoma in the elderly.
Topics: Aged; Anabolic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Nandrolone; Nandrolone Decanoate; Prospective Studies; Remission Induction; Tamoxifen | 1990 |
Hormonal treatment of advanced breast cancer. A randomized trial of tamoxifen versus nandrolone decanoate.
Topics: Breast Neoplasms; Drug Evaluation; Female; Humans; Nandrolone; Nandrolone Decanoate; Random Allocation; Tamoxifen | 1987 |
Nandrolone decanoate added to tamoxifen in the treatment of advanced breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Middle Aged; Nandrolone; Nandrolone Decanoate; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1985 |
8 other study(ies) available for nandrolone and tamoxifen
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients.
Topics: Breast Neoplasms; Female; Humans; Mastectomy; Nandrolone; Nandrolone Decanoate; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Time Factors | 1985 |
Androgen and oestrogen responsiveness of stromal cells derived from the human hyperplastic prostate: oestrogen regulation of the androgen receptor.
Topics: Cells, Cultured; Estradiol; Humans; Male; Nandrolone; Prostate; Prostatic Hyperplasia; Protein Binding; Receptors, Androgen; Stimulation, Chemical; Tamoxifen; Testosterone Congeners | 1994 |
Lack of estrogenic potential of progesterone- or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells.
Topics: Adenocarcinoma; Alkaline Phosphatase; Aminoglutethimide; Aromatase Inhibitors; Binding, Competitive; Cytosol; Endometrial Neoplasms; Endometrium; Enzyme Induction; Enzyme Inhibitors; Estradiol Congeners; Estrogens; Ethinyl Estradiol; Female; Humans; Nandrolone; Norpregnanes; Norprogesterones; Pregnanes; Progesterone; Progestins; Receptors, Estrogen; Tamoxifen; Testosterone; Tumor Cells, Cultured | 1995 |
Steroidal control of male hamster sexual behavior in Me and MPOA: effects of androgen dose and tamoxifen.
Topics: Amygdala; Animals; Contraceptives, Postcoital; Cricetinae; Dose-Response Relationship, Drug; Drug Implants; Estrogen Antagonists; Male; Mesocricetus; Nandrolone; Orchiectomy; Preoptic Area; Sexual Behavior, Animal; Steroids; Stimulation, Chemical; Tamoxifen; Testosterone | 2001 |
Anabolic androgens restore mating after sexual satiety in male rats.
Topics: Anabolic Agents; Androgens; Animals; Dihydrotestosterone; Ejaculation; Estradiol; Female; Flutamide; gamma-Aminobutyric Acid; Male; Nandrolone; Nandrolone Decanoate; Rats; Rats, Wistar; Receptors, Estrogen; Sexual Behavior, Animal; Tamoxifen; Testosterone | 2008 |